Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
暂无分享,去创建一个
Y. Okuno | Shigeo Sato | Ryohei Katayama | M. Kamada | N. Fujita | M. Araki | N. Inase | K. Uchibori
暂无分享,去创建一个
Y. Okuno | Shigeo Sato | Ryohei Katayama | M. Kamada | N. Fujita | M. Araki | N. Inase | K. Uchibori